RetsasSBaylissMSheikhNChongSLBafaloukosD. Chemotherapy of malignant melanoma; The European Experience. Rev Med Interne1990;11(suppl 2):51–8.
2.
SpryCJF. Eosinophils — a comprehensive review and guide to the scientific and medical literature. Oxford: Oxford University Press, 1988.
3.
Vaughan HudsonBLinchDCMacintyreEABennettMHMacLennanKAHudsonVG. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkins disease (BNLI Report No 31): British National Lymphoma Investigation. J Clin Pathol1987;40:247–50.
4.
SiebenscheinRSiebenmannRE. Paraneoplastic eosinophilic leukemoid with eosinophilic parietal thromboendocarditis in malignant melanoma. Schweiz Med Wochenschr1977;107:1257–65.
5.
McKelveyEMLuceJKVaitkeviciusVKTalleyRWBodeyGPLaneM. Combination chemotherapy with bis chloroethyl nitrosurea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma. Cancer1977;39:5–10.
6.
BunnPAJrRidgwayEC. Paraneoplastic Syndromes. In: DeVitaVTJrHellmanSRosenbergSA, eds. Cancer: Principles and practice of oncology. Philadelphia: Lippincott, 1989:1896–920.
